Fennec Pharmaceuticals, Inc. (FENC)
6.79
+0.49
(+7.78%)
USD |
NASDAQ |
Apr 17, 16:00
6.80
+0.01
(+0.15%)
After-Hours: 20:00
Fennec Pharmaceuticals Total Assets (Quarterly) : 70.58M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| CytomX Therapeutics, Inc. | 152.50M |
| Gossamer Bio, Inc. | 172.25M |
| REGENXBIO, Inc. | 453.03M |
| Zymeworks, Inc. | 346.53M |
| Apellis Pharmaceuticals, Inc. | 1.075B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 35.10M |
| Shareholders Equity (Quarterly) | 35.47M |
| Current Ratio | 6.374 |
| Net Debt Paydown Yield | 2.26% |